188 related articles for article (PubMed ID: 38177168)
1. Prognostic and immunological role of adaptor related protein complex 3 subunit mu2 in colon cancer.
Jin Q; Feng J; Yan Y; Kuang Y
Sci Rep; 2024 Jan; 14(1):483. PubMed ID: 38177168
[TBL] [Abstract][Full Text] [Related]
2. [The Expression of RTN1 in Lung Adenocarcinoma and
Its Effect on Immune Microenvironment].
Zhu S; Zu L; Xu S
Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
[TBL] [Abstract][Full Text] [Related]
3. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
4. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
Liang Z; Li X
Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment-associated gene C3 can predict the prognosis of colorectal adenocarcinoma: a study based on TCGA.
Liu Y; Wang X
Clin Transl Oncol; 2021 Sep; 23(9):1923-1933. PubMed ID: 33765255
[TBL] [Abstract][Full Text] [Related]
6. Multi-Omics Analysis of the Prognostic and Immunological Role of Runt-Related Transcription Factor 3 in Pan-Cancer.
Zhou Q; Ding DD; Lu M; Zuo MZ
Crit Rev Eukaryot Gene Expr; 2023; 33(4):63-83. PubMed ID: 37183947
[TBL] [Abstract][Full Text] [Related]
7. The possible role of SRMS in colorectal cancer by bioinformatics analysis.
Zhang J; Liu W; Feng S; Zhong B
World J Surg Oncol; 2021 Nov; 19(1):326. PubMed ID: 34781983
[TBL] [Abstract][Full Text] [Related]
8. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
Front Immunol; 2022; 13():887048. PubMed ID: 35784334
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma.
Yu J; Yang K; Zheng J; Sun X; Zhao W
Gene; 2022 Jan; 808():145990. PubMed ID: 34624456
[TBL] [Abstract][Full Text] [Related]
10. SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer.
Gan C; Li M; Lu Y; Peng G; Li W; Wang H; Peng Y; Hu Q; Wei W; Wang F; Liu L; Zhao Q
BMC Gastroenterol; 2023 Jan; 23(1):4. PubMed ID: 36611136
[TBL] [Abstract][Full Text] [Related]
11. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma.
Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W
Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014
[No Abstract] [Full Text] [Related]
12. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
Front Immunol; 2022; 13():881359. PubMed ID: 35911752
[TBL] [Abstract][Full Text] [Related]
13. Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma.
Qiu C; Shi W; Wu H; Zou S; Li J; Wang D; Liu G; Song Z; Xu X; Hu J; Geng H
Front Immunol; 2021; 12():769685. PubMed ID: 35003085
[TBL] [Abstract][Full Text] [Related]
14. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.
Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M
Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584
[TBL] [Abstract][Full Text] [Related]
15. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
16. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
[No Abstract] [Full Text] [Related]
17. Mutation screening of AP3M2 in Japanese epilepsy patients.
Huang MC; Okada M; Nakatsu F; Oguni H; Ito M; Morita K; Nagafuji H; Hirose S; Sakaki Y; Kaneko S; Ohno H; Kojima T
Brain Dev; 2007 Sep; 29(8):462-7. PubMed ID: 17293072
[TBL] [Abstract][Full Text] [Related]
18. Effects of SMC1A on immune microenvironment and cancer stem cells in colon adenocarcinoma.
Li J; Zhou Q; Liu L; He J
Cancer Med; 2023 Jun; 12(11):12881-12895. PubMed ID: 37096492
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer.
Pan H; Pan J; Wu J
Front Immunol; 2022; 13():934221. PubMed ID: 35967425
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Associated Macrophages Promote Oxaliplatin Resistance
Lan H; Liu Y; Liu J; Wang X; Guan Z; Du J; Jin K
Mol Pharm; 2021 Mar; 18(3):1026-1037. PubMed ID: 33555197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
